Back to XPONANCE LLC XPONANCE LLC

LLYLLY

Showing 8 of 25 quarters

Position history for XPONANCE LLCXPONANCE LLC's holdings in Eli Lilly and Company

Yes. Xponance holds 222,559 shares of LLY (Eli Lilly), worth $266.9M, as of its Q2 2026 13F filing. It reduced the position by 4,284 shares (-1.9%) from Q1 2026. Xponance has held LLY since Q2 2020, across 25 quarterly 13F filings. LLY is 1.6% of Xponance's reported 13F portfolio.

Current Value

$266.9M

Current Shares

222,559

Total Value Change

+$101.5M

Total Shares Change

+35,870

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
222,559
-1.9%
$266.9M1.6%$1,197.71
0
2026-Q1
Increased
226,843
+8.9%
$208.6M1.5%$916.88
53
2025-Q4
Increased
208,322
+5.7%
$223.9M1.7%$1,069.51
51
2025-Q3
Decreased
197,059
-0.4%
$150.4M1.2%$758.22
0
2025-Q2
Increased
197,930
+3.5%
$154.3M1.3%$772.95
49
2025-Q1
Increased
191,203
+2.5%
$157.9M1.5%$817.26
49
2024-Q4
Decreased
186,530
-0.1%
$144M1.3%$762.60
0
2024-Q3
Decreased
186,689
-4.2%
$165.4M1.6%$873.71
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used